John K Chan

No ORCID on file · 4 papers in corpus
rct 2019
Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer
The New England journal of medicine ·doi:10.1056/nejmoa1902626

BACKGROUND: Secondary surgical cytoreduction in women with platinum-sensitive, recurrent epithelial ovarian, primary peritoneal, or fallopian-tube ("ovarian") cancer is widely practiced but has not been evaluated in phase 3 investigation. …

nonrandomized-trial 2018
A phase II evaluation of sunitinib in the treatment of persistent or recurrent clear cell ovarian carcinoma: An NRG Oncology/Gynecologic Oncology Group Study (GOG-254)
Gynecologic Oncology ·doi:10.1016/j.ygyno.2018.05.029

OBJECTIVES: To determine the efficacy and tolerability of sunitinib in recurrent or persistent clear cell ovarian cancer patients. METHODS: All patients had one or two prior regimens with measurable disease. Tumors were at least 50% clear …

case-report 2017
Prolonged survival after intraperitoneal interleukin-2 immunotherapy for recurrent ovarian cancer
Gynecologic oncology reports ·doi:10.1016/j.gore.2017.09.009

•A case report of a 14 year remission of recurrent ovarian cancer with intraperitoneal aldesleukin (IL-2) is presented.•Intraperitoneal IL-2 was given with little toxicity.•Immunotherapy may have the potential for durable remissions in ovar…

observational 2014
Ovarian cancer rates after hysterectomy with and without salpingo-oophorectomy
Obstetrics and gynecology ·doi:10.1097/aog.0000000000000061

OBJECTIVE: To estimate ovarian and peritoneal cancer rates after hysterectomy with and without salpingo-oophorectomy for benign conditions. METHODS: All patients after hysterectomy for benign disease from 1988 to 2006 in Kaiser Permanente …